, Tracking Stock Market Picks
Enter Symbol:
Bristol-myers Squibb Company (BMY) [hlAlert]

Sell BMY
down 46.21 %

Bristol-myers Squibb Company (BMY) rated Sell with price target $36 by MKM Partners

Posted on: Monday,  Oct 27, 2014  11:25 AM ET by MKM Partners

MKM Partners rated Sell Bristol-myers Squibb Company (NYSE: BMY) on 10/27/2014. Previously MKM Partners rated Sell Bristol-myers Squibb Company (NYSE: BMY) on
10/19/2011., when the stock price was $32.71. Since then, Bristol-myers Squibb Company has gained 85.94% as of 12/01/2015's recent price of $60.82.
If you would have followed the previous MKM Partners's recommendation on BMY, you would have lost 46.21% of your investment in 1504 days.

Bristol-Myers Squibb Company is a global leader in the research and development of innovative lifesaving and life-enhancing treatments for heart disease; high blood pressure; stroke; diabetes; cancer; HIV/AIDS and other infectious diseases; depression, schizophrenia and other mental disorders; pain; and other conditions.

MKM Partners LLC is an institutional equity trading and research firm. MKM Partners has extensive experience in the agency execution of U.S. and international equity orders. We provide clients with timely and unbiased economic, technical, and fundamental research.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
10/27/2014 11:25 AM Sell
53.35 36.00
as of 10/17/2014
1 Week down  -0.27 %
1 Month up  0.90 %
3 Months down  -4.13 %
1 YTD up  5.13 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
4/26/2013 11:25 AM Sell
40.10 29.00
10/19/2011 11:25 AM Sell
32.71 26.00

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy